IIBR's CNS Project - Small molecules development
IIBR's CNS group invented and developed an additional of two chemical molecules: AF267B and AF292 that can be used as a basis for the development of an ethical drug aiming to treat CNS neurodegenerative diseases.
We welcome you to contact us for any question or offer for collaborations.
There are some errors in your form.
the mail is recived, thank you